SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).
Laura Ortega MoránFrancisco José Pelegrín MateoRut Porta BalanyàJacobo Rogado RevueltaSilverio Ros MartínezJosé Pablo Berros FombellaElena María Brozos VázquezNatalia Luque CaroJosé Muñoz LangaMercedes Salgado FernándezPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.